Financhill
Back

FibroBiologics Quote, Financials, Valuation and Earnings

FibroBiologics Price Quote

$2.59
-0.01 (7.47%)
(Updated: November 23, 2024 at 5:34 AM ET)

FibroBiologics Key Stats

Sell
16
FibroBiologics (FBLG) is a Sell

Day range:
$2.35 - $2.66
52-week range:
$1.08 - $55.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
32.92%

Volume:
84.7K
Avg. volume:
189.6K
1-year change:
0%
Market cap:
$90.1M
Revenue:
$0
EPS:
$-0.55

How Much Does FibroBiologics Make?

Data Unavailable

Is FibroBiologics Growing As A Company?

Data Unavailable

FibroBiologics Stock Price Performance

  • Did FibroBiologics Stock Go Up Last Month?
    FibroBiologics share price went down by -9.72% last month
  • Did FBLG's Share Price Rise Over The Last Year?
    FBLG share price rose by 0% over the past 1 year

What Is FibroBiologics 52-Week High & Low?

FibroBiologics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy FibroBiologics?

  • How Much Debt Does FibroBiologics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does FibroBiologics Have?
    Cash and short term investments quarterly total is $7.8M
  • What Is FibroBiologics’s Book Value Per Share?
    Book value per share is 0.08

Is FibroBiologics Cash Flow Positive?

  • What Is FBLG Cash Flow From Operations?
    Cash flow from operations (TTM) is -$10.4M
  • What Is FibroBiologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.6M
  • What Is FibroBiologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$87K

FibroBiologics Return On Invested Capital

Data Unavailable

FibroBiologics Earnings Date & Stock Price

FibroBiologics Competitors

  • Who Are FibroBiologics's Competitors?
    Below is a list of companies who compete with FibroBiologics or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Charles River Laboratories International Inc (CRL)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)

FibroBiologics Dividend Yield

FibroBiologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.75
Upside from Last Price: 390.38%

Major Shareholders

  • How many FBLG shares are owned by institutional investors?
    6.6M FBLG shares are owned by institutional investors
  • How many FBLG shares are owned by insiders?
    6.2M FBLG shares are owned by insiders